在瘤发生过程中,Hippo路径的分子机制:治疗意义
Mohamed J Saadh1, Hanan Hassan Ahmed2, Radhwan Abdul Kareem3
1Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
Molecular biology reports
|February 27, 2025
概括
河马信号通路调节组织生长,但其破坏会导致癌症. 了解它的作用和准YAP/TAZ协活性剂为瘤学提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 河马信号通路对于维持组织平衡和器官大小至关重要.
- 河马通路的失调与各种癌症的发展和进展密切相关.
- 这种途径的异常激活有助于瘤中不受控制的细胞增殖和存活.
研究的目的:
- 审查癌症中Hippo路径失调的机制.
- 为了阐明Hippo路径变化和瘤发生之间的分子联系.
- 探索潜在的治疗策略,针对癌症治疗的河马通路.
主要方法:
- 文献综述和对癌症中河马信号通路的现有研究的综合.
- 涉及YAP和TAZ转录协活性剂的分子机制的分析.
- 评估与其他信号网络 (Wnt/β-catenin,PI3K/Akt,TGF-β/SMAD,EGFR) 的相互作用.
主要成果:
- 河马路径失调,通常通过YAP/TAZ激活,通过推动细胞增殖和存活促进瘤发生.
- 与其他信号通路的相互作用放大了Hippo通路中断的致癌潜力.
- 突变和表观遗传修饰是癌细胞中异常Hippo信号的关键驱动因素.
结论:
- 对河马通路调节的全面理解对于开发新型癌症疗法至关重要.
- 针对YAP/TAZ活动和上游组件提供了有前途的治疗途径.
- 需要进一步的研究来将这些发现转化为瘤学和再生医学的有效临床应用.
相关概念视频
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


